Day One Bio (DAWN) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
The line of targeted therapies for children is entering a stage of commercial growth, ensuring a protected patent cycle. Reviewing the EV/EBITDA multiple for Day One (DAWN) over time on GURU.Markets, we see that the 0.00 metric confirms the current valuation level. This is further supported by the high authority of Day One in treating brain tumors, while the orphan drug status of its products guarantees a monopoly position and stable revenue.
DAWN (dayonebio.com): rincian analitis lan laporan miturut indikator
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data utang lan likuiditas:
Utang marang Ekuitas Day One|DAWN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Day One Biopharmaceuticals|DAWN - Utang perusahaan|Rasio utang marang kapitalisasi buku Day One Biopharmaceuticals Inc|DAWN - Utang jangka dawa|Utang jangka cendhak perusahaan Day One Biopharmaceuticals|Indikator likuiditas cepet dayonebio.com
- data bathi bisnis lan rasio investasi:
DAWN - Penghasilan resik perusahaan|Bathi mangsa ngarep Day One|DAWN - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Day One|DAWN - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Day One Biopharmaceuticals Inc|DAWN - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Day One Biopharmaceuticals|DAWN - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan dayonebio.com|DAWN - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Day One
Ringkesan analitik perusahaan:DAWN (Day One Bio)
The EV/EBITDA multiple compares the total enterprise value, including debt, with operating profit, allowing for an assessment of capital management efficiency and debt load. The current value of 0.00 and the fluctuations in the EV/EBITDA level of Day One (DAWN) demonstrate the stability of grant-based financing, which is critical for Day One as it scales distribution and brings its pediatric oncology drug to market.
Analisis pesaing
Incyte Corp. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan HCM|NUVB - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan monopartx.com|Inhibrx Biosciences, Inc. (INBX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi operasional sadurunge panyusutan IMAB|FENC (Fennec Pharmaceuticals Inc) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Heron Therapeutics Inc (HRTX)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Nuvectis Pharma, Inc. (NVCT)|CHRS - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Corbus Pharmaceuticals Holdings CRBP|Cardiff Oncology Inc. - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|BYSI - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioAtla, Inc.|LIXT: Pangali EV/EBITDA|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Citius Pharmaceuticals, Inc. CTXR|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CLRB|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioLineRx Ltd BLRX|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CANF (Can-Fite BioPharma, Ltd.)|APRE (aprea.com) - Nilai bisnis marang bathi operasional sadurunge panyusutan|Kazia Therapeutics Limited - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan SLXN (Silexion Therapeutics Corp.)|NuCana Corp - Pangali EV/EBITDA|Nilai bisnis marang bathi operasional sadurunge panyusutan CMRX (Chimerix Inc.)|CYCC: Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan G1 Therapeutics (GTHX)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Kronos Bio, Inc.|KTRA: Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA ONCT|Pangali EV/EBITDA Portage Biotech Inc (PRTG)
